Bayer (FRA:BAYN) Given a €110.00 Price Target by UBS Group Analysts

UBS Group set a €110.00 ($127.91) target price on Bayer (FRA:BAYN) in a research report report published on Monday, February 4th, www.boersen-zeitung.de reports. The firm currently has a buy rating on the healthcare company’s stock.

Several other equities analysts have also weighed in on BAYN. Credit Suisse Group set a €77.00 ($89.53) price objective on shares of Bayer and gave the company a buy rating in a research note on Tuesday, November 27th. Commerzbank set a €99.00 ($115.12) price objective on shares of Bayer and gave the company a buy rating in a research note on Tuesday, November 27th. Sanford C. Bernstein set a €89.00 ($103.49) price objective on shares of Bayer and gave the company a buy rating in a research note on Monday, October 15th. Goldman Sachs Group set a €78.00 ($90.70) price objective on shares of Bayer and gave the company a buy rating in a research note on Thursday, November 29th. Finally, Nord/LB set a €69.00 ($80.23) price objective on shares of Bayer and gave the company a neutral rating in a research note on Thursday, December 6th. Seven analysts have rated the stock with a hold rating and seventeen have issued a buy rating to the company’s stock. The company presently has a consensus rating of Buy and an average target price of €88.72 ($103.16).

BAYN traded up €1.15 ($1.34) on Monday, reaching €71.43 ($83.06). The company had a trading volume of 3,306,575 shares. Bayer has a one year low of €91.58 ($106.49) and a one year high of €123.82 ($143.98).

Bayer Company Profile

Bayer Aktiengesellschaft operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, Crop Science, and Animal Health segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents.

See Also: How to Profit and Limit Losses With Stop Orders

Analyst Recommendations for Bayer (FRA:BAYN)

Receive News & Ratings for Bayer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bayer and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply